Research Units
State Key Laboratory for Diagnosis & Treatment of Infectious Diseases
From benchside to the bedside

Mission

To significantly reduce the incidence of infectious diseases and the associated mortality rate in China and become a world-class academic center in diagnosis and treatment of infectious diseases

Basic Information

  • Founded in 2007

  • Director: Professor LI Lanjuan, Member of National Academy of Engineering

  • Space Areas: 3000+ m2

  • Ward Beds: 300

  • Research Platforms: 14

  • Total Value of Instruments and Equipment: 160 million Yuan

  • Collaborative Innovation Center: 1

Research Focuses

  • Pathogenesis, prevention and treatment techniques for viral hepatitis

  • The diagnosis, prevention and treatment of AIDS

  • Infectious microecology, infectious immunology

  • Diagnosis and treatment of emerging and recurring infectious diseases

Achievements

  • Number of National Science & Technology Progress Awards (2013-2017): 4

  • Number of National Grants (2013-2017): 150

  • Total Amount of Funding (2013-2017): 210 million Yuan

  • Number of SCI Publications (2013-2017): 500+

  • Number of Patents (2013-2017): 40+

  • Long-term Partnerships: Pasteur Institute, NIH, UCLA & the University of Hong Kong, etc.

  •   Significant Breakthroughs:               

    • Establishment of Artificial Liver System (Li-ALS) for treating severe liver diseases

    • Discovery on importance of the Gut Microbiome of Liver Cirrhosis Patients

    • Rapid and efficient response to emerging infectious diseases, especially H7N9 outbreak

  • International Recognition By: Editor from world class journal (such as Lancet); the US Department of Health; US CDC

Contact

E-mail: lilj@zju.edu.cn